AAAAAA

   
Results: 1-9 |
Results: 9
DEVELOPMENT OF NONLINEAR-REGRESSION MODELS FOR COVARIATES WITH MEASUREMENT ERRORS
Authors: YOUNG D PISCITELLI DA BIGORA S
Citation: D. Young et al., DEVELOPMENT OF NONLINEAR-REGRESSION MODELS FOR COVARIATES WITH MEASUREMENT ERRORS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 84-84
PAVLOVIAN FOOD EFFECT ON THE ENTEROHEPATIC RECIRCULATION OF PIROXICAM
Authors: POLLI JE BIGORA S PISCITELLI DA STRAUGHN AB YOUNG D
Citation: Je. Polli et al., PAVLOVIAN FOOD EFFECT ON THE ENTEROHEPATIC RECIRCULATION OF PIROXICAM, Biopharmaceutics & drug disposition, 17(7), 1996, pp. 635-641
POPULATION PHARMACOKINETICS (PPK) OF FAMIPRIDINE DETERMINED BY 2 PROGRAMS - NONMEM AND PPHARM
Authors: PISCITELLI DA DOWELL JA BUTLER J DEVANE J YOUNG D
Citation: Da. Piscitelli et al., POPULATION PHARMACOKINETICS (PPK) OF FAMIPRIDINE DETERMINED BY 2 PROGRAMS - NONMEM AND PPHARM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 67-67
EFFECT OF PHARMACODYNAMIC BASE-LINE CHANGES IN LINKED AND INDIRECT PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELS
Authors: YOUNG D PISCITELLI DA
Citation: D. Young et Da. Piscitelli, EFFECT OF PHARMACODYNAMIC BASE-LINE CHANGES IN LINKED AND INDIRECT PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 103-103
EXPOSURE PARAMETERS AND OUTCOME OF CMV RETINITIS FOR ORAL GANCICLOVIR
Authors: PLAISANCE K PISCITELLI DA YOUNG D BIGORA S PERDUE B KEAY S GAINES K JUNG D BUHLES W
Citation: K. Plaisance et al., EXPOSURE PARAMETERS AND OUTCOME OF CMV RETINITIS FOR ORAL GANCICLOVIR, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 177-177
POPULATION PHARMACOKINETIC ANALYSIS (PPK) WITH DOSE-DEPENDENT BIOAVAILABILITY
Authors: YOUNG D FOSSLER MJ PISCITELLI DA MENDELL RJ CHEUNG W CHAN K
Citation: D. Young et al., POPULATION PHARMACOKINETIC ANALYSIS (PPK) WITH DOSE-DEPENDENT BIOAVAILABILITY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 189-189
NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF CGP-48933
Authors: PISCITELLI DA YOUNG D PRASAD P CHAN K
Citation: Da. Piscitelli et al., NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF CGP-48933, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214
NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF ORAL GANCICLOVIR (GA)
Authors: PISCITELLI DA PLAISANCE K YOUNG D BIGORA S PERDUE B GAINES K JUNG D BUHLES W
Citation: Da. Piscitelli et al., NONLINEAR MIXED EFFECTS MODELING (NONMEM) OF THE POPULATION PHARMACOKINETICS (PPK) OF ORAL GANCICLOVIR (GA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214
BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE - IMPLICATIONS FOR CLINICAL USE OF THE IMMEDIATE AND CONTROLLED-RELEASE DOSAGE FORMS
Authors: PISCITELLI DA FISCHER JH SCHOEN MD HOON TJ BAUMAN JL
Citation: Da. Piscitelli et al., BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE - IMPLICATIONS FOR CLINICAL USE OF THE IMMEDIATE AND CONTROLLED-RELEASE DOSAGE FORMS, Journal of clinical pharmacology, 34(8), 1994, pp. 823-828
Risultati: 1-9 |